SCHEMBL5497904

SCHEMBL5497904

C[C@@H](O)[C@H](N)C(=O)c1ccc([C](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.46
CES2 O00748 2/20 0.46
CES1 P23141 2/20 0.46
PGR P06401 1/20 0.43
ADRA2A P08913 1/20 0.43
ADRA2B P18089 1/20 0.43
HTR2A P28223 1/20 0.43
HRH1 P35367 1/20 0.43
KCNH2 Q12809 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
MAPT P10636 3/20 0.41
HTT P42858 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
ATM Q13315 2/20 0.41
MAPK1 P28482 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.40
ALKBH5 Q6P6C2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30309190 0.92 LMNA (0.52) LMNACES2CES1PGRADRA2A
SCHEMBL8507553 0.82 CES2 (0.49) CES2CES1PGRADRA2AADRA2B
SCHEMBL19318480 0.80 PGR (0.48) LMNACES2CES1PGRADRA2A
SCHEMBL7432353 0.80 PGR (0.48) LMNACES2CES1PGRADRA2A
SCHEMBL8228098 0.80 PGR (0.48) LMNACES2CES1PGRADRA2A
Hydrochloric Acid SCHEMBL10728681 0.79 MAPT (0.49) LMNACES2CES1PGRADRA2A
Hydrochloric Acid SCHEMBL10728669 0.79 MAPT (0.49) LMNACES2CES1PGRADRA2A
SCHEMBL11499402 0.76 PTGS2 (0.50) LMNAHTR2AMAPTMAPK1ALDH1A1
SCHEMBL11499403 0.76 PTGS2 (0.50) LMNAHTR2AMAPTMAPK1ALDH1A1
Dealkylated Diethylpropion SCHEMBL25176894 0.76 TDP1 (0.52) LMNACES2CES1PGRADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1754705-A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders Genentech, Inc. (US) 2007-02-21 EP disclosed
EP-1063982-B1 ANTAGONISTS FOR TREATMENT OF CD11/CD18 ADHESION RECEPTOR MEDIATED DISORDERS GENENTECH INC (US) 2007-02-14 EP disclosed